Erlotinib Completed Phase N/A Trials for Lung Cancer Non-Small Cell Cancer (NSCLC) Treatment

IndicationsStatusPurposePhase
CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00125372Study of Tarceva and Targretin in Stage I-II Lung Cancer